ClinicalTrials.Veeva

Menu

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being (CAPSULE)

Imperial College London logo

Imperial College London

Status

Enrolling

Conditions

Chronic Pulmonary Aspergillosis

Study type

Observational

Funder types

Other

Identifiers

NCT06885905
23IC8471

Details and patient eligibility

About

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. All patients >/= 18 years old and able to provide informed consent
  2. Patients with a diagnosis of chronic pulmonary aspergillosis
  3. To speak and understand English
  4. Able to provide informed consent

Trial contacts and locations

3

Loading...

Central trial contact

Dareen Marghlani, MSc; Anand Shah, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems